Published in J Virol on May 06, 2009
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
MAVS protein is attenuated by rotavirus nonstructural protein 1. PLoS One (2014) 1.48
The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J Virol (2011) 1.30
IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation. J Virol (2009) 1.29
Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J Virol (2010) 1.18
Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains. J Virol (2010) 1.13
Rotavirus immune responses and correlates of protection. Curr Opin Virol (2012) 1.11
The battle between rotavirus and its host for control of the interferon signaling pathway. PLoS Pathog (2013) 1.00
Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract. J Virol (2010) 0.94
Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog (2010) 0.92
The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells. J Virol (2012) 0.91
Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain. J Virol (2013) 0.91
Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model. Immunology (2010) 0.89
Molecular epidemiology and genetic evolution of the whole genome of G3P[8] human rotavirus in Wuhan, China, from 2000 through 2013. PLoS One (2014) 0.88
Rotavirus NSP1 protein inhibits interferon-mediated STAT1 activation. J Virol (2013) 0.88
Rotaviruses reach late endosomes and require the cation-dependent mannose-6-phosphate receptor and the activity of cathepsin proteases to enter the cell. J Virol (2014) 0.88
Characterization of rotavirus RNAs that activate innate immune signaling through the RIG-I-like receptors. PLoS One (2013) 0.87
Permissive replication of homologous murine rotavirus in the mouse intestine is primarily regulated by VP4 and NSP1. J Virol (2013) 0.86
Rotavirus antagonism of the innate immune response. Viruses (2009) 0.86
Inflammatory and oxidative stress in rotavirus infection. World J Virol (2016) 0.76
The Rotavirus Interferon Antagonist NSP1: Many Targets, Many Questions. J Virol (2016) 0.76
Rhesus rotavirus VP4 sequence-specific activation of mononuclear cells is associated with cholangiopathy in murine biliary atresia. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
Experimental Adaptation of Rotaviruses to Tumor Cell Lines. PLoS One (2016) 0.75
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol (1998) 7.43
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med (1999) 3.45
Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol (1999) 2.93
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol (1999) 2.51
Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci U S A (2005) 2.30
Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol (2007) 1.71
Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J Virol (2002) 1.67
STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol (2002) 1.66
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog (2009) 1.50
Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab Immunol (2003) 1.42
Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J Gen Virol (2007) 1.32
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol (2002) 1.32
Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology (1997) 1.30
Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization. Virology (1994) 1.30
Psoralen preparation of antigenically intact noninfectious rotavirus particles. J Virol Methods (1992) 1.30
Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol (2008) 1.28
Rotavirus: to the gut and beyond! Curr Opin Gastroenterol (2007) 1.23
Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice. J Interferon Cytokine Res (1999) 1.20
The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res (2003) 1.19
Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol (1996) 1.10
Rotavirus induces alpha-interferon release in children with gastroenteritis. J Pediatr Gastroenterol Nutr (1993) 1.07
Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Mol Biother (1990) 1.07
Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells. J Immunol (2007) 1.01
Treatment of extrahepatic biliary atresia with interferon-alpha in a murine infectious model. Pediatr Res (1997) 0.99
Rotavirus-specific subclass antibody and cytokine responses in Bangladeshi children with rotavirus diarrhoea. J Med Virol (2003) 0.94
Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts. J Virol (2007) 0.92
Interferon response in colostrum-deprived newborn calves infected with bovine rotavirus: its possible role in the control of the pathogenicity. Ann Rech Vet (1984) 0.86
Rotavirus immunity in the mouse. Arch Virol Suppl (1996) 0.83
[Dynamic variation of serum and stool level of interleukin-2, interleukin-6 and interferon-alpha in children with rotavirus enteritis and its relation to clinical manifestations]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2002) 0.82
[Parasitologic, bacteriologic and virological studies of feces in diarrhea in 212 non-hospitalized children in Dakar. Application of the concept of mass opportunistic infections]. Bull Soc Pathol Exot Filiales (1984) 0.79
Exact significance levels for multiple binomial testing with application to carcinogenicity screens. Biometrics (1981) 0.78
An STS-based map of the human genome. Science (1995) 17.72
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol (1977) 4.02
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58
Missing women. BMJ (1992) 3.44
The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol (2007) 3.34
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23
Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology (1987) 3.22
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
The folding mechanism of a beta-sheet: the WW domain. J Mol Biol (2001) 3.00
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol (1986) 2.97
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol (1993) 2.90
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med (1976) 2.80
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy (2004) 2.69
Concept for easy fiberoptic intubation via a laryngeal airway mask. Anesth Analg (1999) 2.67
Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol (1999) 2.65
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA (1998) 2.60
Proteins of Norwalk virus. J Virol (1981) 2.59
Viral gastroenteritis. N Engl J Med (1991) 2.58
Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am (1999) 2.49
Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
The genome-associated, specific RNA binding proteins of avian and mammalian type C viruses. Cell (1977) 2.42
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38
Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A (1986) 2.37
An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet (2000) 2.36
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest (2000) 2.32
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Isolation and characterization of a canine rotavirus. Arch Virol (1982) 2.26
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest (2001) 2.23
Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res (1999) 2.21
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization. J Clin Microbiol (2002) 2.12
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J Virol (1988) 2.12
Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J (2000) 2.11
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int (2001) 2.06
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood (2001) 2.05
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05
Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem (1997) 2.05
Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA. Cell (1977) 2.04
Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J Clin Microbiol (1992) 2.03
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity. Proc Natl Acad Sci U S A (1978) 2.01
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol (1991) 1.99
Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes. Virology (1989) 1.99
Is oral rice electrolyte solution superior to glucose electrolyte solution in infantile diarrhoea? Arch Dis Child (1982) 1.99
Catalysis research of relevance to carbon management: progress, challenges, and opportunities. Chem Rev (2001) 1.99
Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology (1988) 1.98
Adaptive electric field control of epileptic seizures. J Neurosci (2001) 1.96
Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis (1986) 1.95
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis (1983) 1.94